About
Cadence, founded in 2020 in New York, USA, uses clinical AI and remote patient monitoring to automate home-based care for chronic conditions including heart failure, hypertension, and diabetes.
Full tier & rationale — an SVTR Intelligence benefit
Capital graph
Funding history
- 2021-12-14Series B$100M
Investors · Spark Capital, Coatue, Thrive Capital, General Catalyst, B Capital, Corewell Health Ventures, Memorial Hermann, Duke HealthSource · businesswire.com ↗
- 2021-08Series A$41M
Investors · General Catalyst (co-lead), Thrive Capital (co-lead)Source · fiercebiotech.com ↗
Comparable companies· by market
This company
BusinessLatest roundTotal raisedDate- Cadence
Clinical AI for at-home monitoring of chronic diseases
Series B · $241M · 2021-12
$241M
United States
BusinessLatest roundTotal raisedDate- Qualified Health
Enterprise platform that helps health systems deploy and govern generative AI across clinical and administrative workflows
Series B · $250M · 2026-03
$250M - Suki
Ambient AI assistant for healthcare (clinical documentation, coding and administrative automation)
Series D+ · $250M · 2026-10
$250M - Pomelo Care
Value-based virtual care platform for expectant mothers and families with newborns: multidisciplinary clinical teams (obstetricians, midwives, doulas…
Series C · $171M · 2026-01 · Valuation $1.7B
$171MValuation $1.7B
China
BusinessLatest roundTotal raisedDate- 格式塔科技
Ultrasound brain-computer interface for whole-brain read/write, treating chronic pain, stroke rehabilitation, PTSD and other neurological conditions
Angel · $80M · 2026-07
$80M - Purui Intelligence
AI-driven platform for end-to-end clinical trial automation and results delivery.
Series A · $14M · 2026-06
$14M
Europe
BusinessLatest roundTotal raisedDate- Tandem Health
AI clinical assistant for European healthcare providers: pre-visit summaries, real-time consultation transcription…
Series B · $160M · 2026-09
$160M - Tucuvi
Voice AI that automates clinical follow-up and care management workflows
Series A · $184M · 2026-01
$184M - Corti
Uses AI to assess patients in collaboration with clinicians
Series B · $60M · 2023-09
$60M
Other / unspecified
BusinessLatest roundTotal raisedDate- Heidi Health
AI ambient documentation and clinical agent for clinicians (AI Care Partner)
Series C · $437M · 2026-09 · Valuation $900M
$437MValuation $900M - Reliant AI
Uses generative AI to help biopharma companies organize and analyze data for clinical trials or scientific publications
Seed · $11M · 2024-08
$11M - Cloudphysician
RADAR tele-ICU platform and AI tools (NETRA, AIRA, HERA, SWARA) for remote critical care at private and public hospitals in India
$4M
$4M
Confirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.
Investors that may fit
Y Combinator
39 Life Sciences deals in the last 24 months · 21 at a nearby stage · 32 in NYC Metro
Request intro →Andreessen Horowitz
22 Life Sciences deals in the last 24 months · 13 at a nearby stage · 20 in NYC Metro
Request intro →Khosla Ventures
21 Life Sciences deals in the last 24 months · 11 at a nearby stage · 20 in NYC Metro
Request intro →Lightspeed
16 Life Sciences deals in the last 24 months · 10 at a nearby stage · 14 in NYC Metro
Request intro →8VC
15 Life Sciences deals in the last 24 months · 10 at a nearby stage · 15 in NYC Metro
Request intro →Lux Capital
15 Life Sciences deals in the last 24 months · 8 at a nearby stage · 15 in NYC Metro
Request intro →Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.